Viewing nowCombinationEzrovah Tablets 10/10 mg
Rosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.

MFDS item code 201606044 · Approved 2016.10.12 · Insurance code 643704380
Improvement of primary hypercholesterolemia and mixed dyslipidemia
This medication is used as an adjunct to diet in patients with primary hypercholesterolemia (heterozygous familial and non-familial) or mixed dyslipidemia to reduce total cholesterol, LDL cholesterol, Apo B protein, triglycerides, non-HDL cholesterol levels and to increase HDL cholesterol levels. Care should be taken to consider risk factors particularly when administering to patients at increased risk of atherosclerotic vascular disease due to hypercholesterolemia. This medication must be used together with an appropriate diet that restricts saturated fat and cholesterol intake, and is used when diet and non-drug measures are insufficient. Before treatment, other causes of dyslipidemia such as diabetes and hypothyroidism should be identified and treated if necessary, and treatment efficacy should be evaluated through lipid testing. Additionally, following an acute coronary event, lipid levels should be measured promptly to inform treatment planning. This medication is used to improve dyslipidemia and reduce the risk of cardiovascular disease.
This medicine should be administered once daily, regardless of meals. Patients should continue a standard cholesterol-lowering diet before and during treatment with this medicine. The dose should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Primary hypercholesterolemia The dosage range is 10/5 mg to 10/20 mg once daily. The recommended starting dose is 10/5 mg once daily. The dose may be adjusted for patients who require a greater reduction in LDL cholesterol. After starting treatment or adjusting the dose, blood lipid levels should be checked at intervals of at least 4 weeks, and the dose adjusted accordingly; it may be increased up to a maximum of 10/20 mg once daily. Patients taking ezetimibe and rosuvastatin concomitantly may switch to this medicine (a combination product with the same amounts of each active ingredient) for convenience.
This medication is a combination product containing both Rosuvastatin and Ezetimibe, primarily used for the treatment of hypercholesterolemia. Patients with muscle-related diseases or at risk of acute renal failure should use caution before taking this drug. If there are acute infections, hypotension, major surgery, trauma, or severe metabolic disorders, the use of this drug may need to be temporarily or completely halted. The following patients should not take this drug: those with allergies to its ingredients, those with active liver disease, those with unexplained persistent elevations in liver enzymes, those with muscle diseases, those currently taking cyclosporine, those with severe renal failure, pregnant women or women of childbearing potential, nursing mothers, and patients at high risk of myopathy or rhabdomyolysis. Patients particularly at risk for myopathy should have their serum creatine kinase (CPK) levels checked before administration, and if symptoms such as muscle pain, muscle cramps, or muscle weakness occur, they should consult a doctor immediately. If CPK levels exceed five times the upper limit of normal, this medication should be discontinued. Patients with liver function issues should also exercise caution. Those with elevated liver enzyme levels or signs of liver damage should undergo regular liver function tests, and if serious liver damage is suspected, this medication should be discontinued. This medication may interact with other drugs, so any currently taken medications should be reported to a physician. This is particularly important when used in conjunction with cyclosporine, fibrate-class medications, and anticoagulants such as warfarin. Pregnant or nursing women should not take this medication, and women of childbearing age should ensure appropriate contraception while taking it. Elderly patients or those with impaired renal function are also at high risk for myopathy and should exercise caution, while safety in pediatric patients has not been established and is therefore not recommended. In case of overdose, treatment and supportive care should be based on symptoms, and monitoring of liver function tests and blood CPK levels is crucial. This medication should be kept out of reach of children, and care should be taken not to change the container as it may negatively affect the quality.
pharyngitis, arthralgia, headache, elevated ALT, elevated AST, myalgia, edema, increased serum bilirubin, acneiform dermatitis, pruritus, dizziness, upper respiratory tract infection, chest pain, facial edema, odd sensations, drug intolerance, colon polyps, irritable bowel syndrome, esophagitis, hypersomnia, neurodegenerative disorders, postural dizziness, migraine, diabetes, glucose tolerance disorder, depression, bronchitis, rhinitis, cystitis, dermatophyte infection of nails, soft tissue inflammation, hepatic steatosis, liver dysfunction, hepatotoxicity, acute hepatitis, toxic hepatitis, increased gamma-glutamyltransferase, increased blood cholesterol, increased serum alkaline phosphatase, irregular heart rate, osteoarthritis, osteoporosis, musculoskeletal stiffness, musculoskeletal discomfort, muscle weakness, diaphoresis, dermatitis, skin burning sensation, skin disorders, alopecia, oropharyngeal pain, nasal congestion, respiratory difficulties, pelvic pain, breast cysts, ptosis, diabetic retinopathy, ear discomfort, renal dysfunction, benign esophageal neoplasm, angioedema, thrombocytopenia, jaundice, hepatitis, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, cognitive impairment, asthenia, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myopathy, myositis, rhabdomyolysis, urticaria, hyperhidrosis, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, nausea, diarrhea, anorexia, abdominal distension, abnormal liver function tests, myalgia, joint pain, increased CK, elevated serum creatinine, hypertension, increased blood urea, elevated CPK, abnormal liver function tests, fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, chest pain, dizziness, headache, fatigue, bloating, nausea, increased AST, increased ALT, myalgia, anaphylaxis, urticaria, rash, angioedema, erythema multiforme, cholelithiasis, cholecystitis, tremors, epigastric pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disturbances, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, rhinorrhea, limb pain, diabetic neuropathy, anemia, splenomegaly, conjunctival hyperemia, renal failure, liver dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it must be stored in a sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius at room temperature to maintain the medication's effectiveness for a longer time.
White to almost white round film-coated tablets
30 tablets (15 tablets/PTP × 2)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Kukje Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication · Combination
Hanmi Pharmaceutical Co., Ltd.
CombinationRosuvastatin Calcium 5.2mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogen Korea Co., Ltd.
CombinationRosuvastatin Calcium 20.8mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Albogene Korea Co., Ltd.
CombinationRosuvastatin Calcium 10.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Daewoong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.